Related Experiment Video
Updated: Jun 13, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Inflammation, aging, and cancer vaccines
Mauro Provinciali1, Alessandra Barucca, Maurizio Cardelli
1Advanced Technology Center for Aging Research, Scientific Technological Area, INRCA-IRCCS, Ancona, Italy. m.provinciali@inrca.it
Aging causes immune system changes and chronic inflammation, increasing cancer risk. Anti-inflammatory interventions may enhance cancer vaccines
Area of Science:
- Immunology
- Oncology
- Gerontology
Background:
- Immunosenescence, characterized by chronic low-grade inflammation, is linked to increased cancer risk and progression.
- Cancer vaccines, a promising immunotherapy, show reduced efficacy in older adults compared to younger individuals.
Purpose of the Study:
- To review the impact of aging and inflammation on cancer development and progression.
- To explore the potential of modulating inflammation to improve cancer vaccine effectiveness in the elderly.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of the relationship between age-related inflammation and cancer.
- Speculative analysis on anti-inflammatory interventions for cancer immunotherapy.
Main Results:
- Persistent inflammation is a risk factor for cancer development and progression.
- Cancer vaccine efficacy is diminished in older individuals due to immunosenescence.
- Anti-inflammatory strategies show potential for enhancing cancer vaccine responses.
Conclusions:
- Modulating inflammation may be a viable strategy to improve cancer immunotherapy outcomes in aging populations.
- Further research into anti-inflammatory interventions is warranted to boost cancer vaccine effectiveness in the elderly.
More Related Videos
07:58Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
Published on: April 16, 2012
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Tumor Immunotherapy
Vaccines
Inflammation
Psychoneuroimmunology: Diabetes and Cancer